Acorah Software Products - Accounts Production 16.1.300 false true 30 September 2023 4 September 2022 false true No description of principal activity 1 October 2023 30 September 2024 30 September 2024 14334705 Mr M R Kabir iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14334705 2023-09-30 14334705 2024-09-30 14334705 2023-10-01 2024-09-30 14334705 frs-core:CurrentFinancialInstruments 2024-09-30 14334705 frs-bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 14334705 frs-bus:FilletedAccounts 2023-10-01 2024-09-30 14334705 frs-bus:Micro-entities 2023-10-01 2024-09-30 14334705 frs-bus:AuditExempt-NoAccountantsReport 2023-10-01 2024-09-30 14334705 frs-bus:Director1 2023-10-01 2024-09-30 14334705 2022-09-03 14334705 2023-09-30 14334705 2022-09-04 2023-09-30 14334705 frs-core:CurrentFinancialInstruments 2023-09-30
Registered number: 14334705
KARM Pharma Ltd
Financial Statements
For The Year Ended 30 September 2024
Balance Sheet
Registered number: 14334705
30 September 2024 30 September 2023
£ £
Fixed assets 1,167 1,459
Current assets 718 8,985
Creditors: Amounts Falling Due Within One Year (827 ) (9,113 )
NET CURRENT LIABILITIES (109 ) (128 )
TOTAL ASSETS LESS CURRENT LIABILITIES 1,058 1,331
Accruals and deferred income (880 ) (670 )
NET ASSETS 178 661
CAPITAL AND RESERVES 178 661

Notes

1. General Information
KARM Pharma Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14334705 . The registered office is 113 Harewood Terrace, Southall, UB2 4JN.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2023: 2)
2 2
For the year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr M R Kabir
Director
19th February 2025